Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma among 4 stocks to hit 52-week highs & rally up to 25% in a month
The Sensex ended higher as select BSE 200 stocks touched fresh 52-week highs. FSN E-Commerce Ventures, Titan, Sun Pharmaceutical Industries and Lenskart Solutions led the momentum.

Buy, Sell Or Hold: Titan, Britannia, Bharat Rasayan, Kirloskar Pneumatic, ICICI Prudential — Ask Profit
Buy Sell Hold
Groww, Lenskart, 9 other stocks among Motilal’s non-Nifty ideas. Check full list
Motilal Oswal has revealed its top non-Nifty stock picks. The brokerage anticipates robust earnings growth for these companies. Key names include ICICI Prudential AMC, TVS Motor, and Dixon Technologies. Delhivery shows the highest projected earnings expansion. Investors can explore these opportunities for potential gains.

Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Tata Power, Sona BLW shares on 1 June
Indian benchmark indices opened higher on June 1, supported by gains in IndiGo and Asian Paints. The NSE Nifty rose 0.38% and the BSE Sensex gained 0.36% amid positive Asian market sentiment and recovery after recent sell-offs.

When markets panic, valuations don’t: A case for staying invested
Amid heightened global uncertainty and sharp market swings, long-term investors should focus on intrinsic value rather than short-term price movements, says Gautam Sinha Roy of ICICI Prudential Life Insurance. He argues that India’s resilient macro fundamentals, stabilising earnings cycle and moderating valuations continue to support the case for staying invested through volatility.
BSE vs MCX: Which stock are you betting on? Jefferies, Morgan Stanley, others have their say
Amidst market volatility, Indian stock exchanges BSE and MCX have seen significant rallies, driven by increased trading activity. Both reported strong Q4 earnings. While Jefferies and ICICI Securities remain cautious on BSE, citing stagnant market share, brokerages like HDFC Securities and Morgan Stanley are more optimistic about MCX, highlighting its growth drivers in commodity trading.

Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainers
Indian stocks marginally gained on May 18, driven by strong tech buying and pharma support, with Nifty 50 up 0.03% at 23,649 and BSE Sensex at 75,263. However, the broader market faced pressure as Nifty Midcap 100 and Nifty Smallcap 100 fell.

Here's why ICICI Prudential Life Insurance shares will be in focus on Monday
Shares of ICICI Prudential Life Insurance are down 21% so far in 2026, underperforming its peers such as HDFC Life, which is down 19%, LIC, which has declined 6%, and SBI Life, which is down 9% so far this year. The stock though, continues to trade above its issue price of ₹334.

CLSA says Nifty has given a new signal on the charts; check potential returns and top midcap 'buys'
Laurence Balanco of CLSA has shared five midcap ideas: BSE, MCX, Apollo Tubes, Dixon Technologies and Aurobindo Pharma.

ICICI Prudential Life shares gain 4% as analysts say growth outlook intact
The management refrained from providing guidance for FY27, reiterating its focus on new business profitability. The company also plans to adopt Indian Accounting Standards from FY28, following a one year forbearance.

ICICI Prudential AMC shares decline 3% after Q4 results; Analysts see up to 16% upside
Brokerage firm CLSA has an 'outperform' rating on the stock, while Citi, HSBC, UBS have 'buy' recommendations and Morgan Stanley has an 'equal weight' rating. HSBC and UBS have also raised their price targets on the stock.
Stocks to watch: LIC, HAL, GAIL, ICICI Prudential AMC among 10 shares in focus today - Mint
Stocks to watch: LIC, HAL, GAIL, ICICI Prudential AMC among 10 shares in focus todayMint